Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.

Joseph Biederman1, Thomas Spencer, Timothy Wilens

  • 1Massachusetts General Hospital, ACC-725, Boston, MA 02114, USA. Biederman@helix.mgh.harvard.edu

The International Journal of Neuropsychopharmacology
|January 22, 2004
PubMed
Summary

Pharmacological treatments, including stimulants and atomoxetine, effectively reduce core symptoms of attention-deficit hyperactivity disorder (ADHD) across the lifespan. Further research is needed for diverse populations and complex cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening for Attention-Deficit/Hyperactivity Disorder and Comorbidities in a Diverse, Urban Primary Care Setting.

Clinical pediatrics·2018
Same author

Does the course of manic symptoms in pediatric bipolar disorder impact the course of conduct disorder? Findings from four prospective datasets.

Journal of affective disorders·2018
Same author

Informativeness of Self-Reports of ADHD Symptoms in Monitoring Response to Stimulant Treatment in Clinically Referred Adults With ADHD.

Journal of attention disorders·2018
Same author

Attention and working memory deficits in a perinatal nicotine exposure mouse model.

PloS one·2018
Same author

High Risk for Severe Emotional Dysregulation in Psychiatrically Referred Youth with Autism Spectrum Disorder: A Controlled Study.

Journal of autism and developmental disorders·2018
Same author

The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone.

The Journal of clinical psychiatry·2018

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Attention-deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder impacting individuals across all age groups.
  • Numerous pharmacological agents have demonstrated efficacy in managing ADHD core symptoms and associated functional impairments.
  • Stimulants and atomoxetine are well-documented treatments, improving behavior, cognition, self-esteem, and social functioning.

Purpose of the Study:

  • To review the existing literature on the efficacy of pharmacological treatments for ADHD.
  • To identify gaps in current research regarding ADHD pharmacotherapy.
  • To highlight the need for further investigation into diverse populations and treatment combinations.

Main Methods:

  • Systematic review of existing literature on ADHD pharmacotherapy.

Related Experiment Videos

  • Analysis of studies documenting the efficacy of various pharmacological agents.
  • Identification of research trends and limitations in ADHD treatment literature.

    • Main Results:

    • Stimulants and atomoxetine show significant efficacy in reducing ADHD symptoms and improving overall function.
    • Treatment response can vary based on age, specific comorbidities, and individual patient factors.
    • Current research predominantly focuses on school-aged Caucasian boys, indicating a need for broader study populations.

    Conclusions:

    • Pharmacological interventions play a crucial role in managing ADHD symptoms and improving quality of life.
    • Further research is essential to explore alternative treatments, optimize established therapies for diverse groups, and investigate combination treatments for complex ADHD cases.
    • Addressing treatment disparities and expanding research scope are critical for comprehensive ADHD care.